This is not a
A very serious allergic reaction to this drug is rare
Molnupiravir is an oral, small-molecule antiviral prodrug that Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble
Less common Diarrhea dizziness headache hives, itching, skin rash nausea redness of the skin vomiting Molnupiravir’s side effects are generally mild and don’t seem to happen very often
Molnupiravir accelerates viral load decline, but virus is detectable by Day 5 in most cases
The most common reported ADRs were diarrhoea (57; 4
The most frequent adverse reactions reported with molnupiravir in the U
Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses
Few adverse effects were reported, with the most notable—folded ears (1), broken whiskers (1), and severe leukopenia (1)—seen at dosages above 23 mg/kg twice daily
LAGEVRIO™ (molnupiravir) is an investigational medicine used to treat adults with mild-to-moderate COVID-19: who are at risk for progression to severe COVID-19 including hospitalization or death, and for whom other
At least one study in animal cell cultures found mutations in cells treated with molnupiravir and recommends to assess mutagenic potential and potential genotoxic side effects in vivo, focusing on rapidly dividing cells
Lagevrio (molnupiravir) Home Clinical resources COVID-19 resources Clinical care Oral treatments for COVID-19 – Prescribing information for GPs Lagevrio (molnupiravir) The most common side effects of Lagevrio are diarrhoea, nausea and dizziness
Side effects: Diarrhea, nausea, and dizziness are the most common side effects
Merck plans Side Effects
authorization for lagevrio™ (molnupiravir) capsules
Based on the potential for adverse reactions in the infant from LAGEVRIO, breastfeeding is not recommended during treatment with LAGEVRIO and for 4 days after the final dose
These are not all the possible side effects of LAGEVRIO
Again, no dose-limiting side effects or laboratory safety concerns were identified